GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD17B2, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
14.3386 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, NR3C1, PIK3CA, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR |
12.5273 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, ESR1, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, INSR, NR3C1, PIK3CA, PTGS2, RORC, SLC6A3, SRC, TEK, TRPV1, TYR |
10.7905 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, NR3C1, PIK3CA, PTGS2, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR |
10.7905 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SLC6A3, SRC, TEK, TRPV1, TYR |
10.4297 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B2, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, TRPV1 |
9.73184 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, PIK3CA, PIK3CB, SMAD3, TRPV1 |
9.2661 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.2661 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.26082 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
9.14752 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
9.14752 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, EGFR, GRIK5, INSR, PTGS2, SLC1A1, SLC6A2, SLC6A3, SMAD3, TRPV1 |
9.12496 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, ALOX12, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC, TRPV1 |
8.85639 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.62079 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.47467 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.3638 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, NR3C1, NUAK1, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR |
8.20851 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.95215 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F10, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
7.81611 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, NR3C1, PIK3CA, PTGS2, RORC, SMAD3, SRC, TRPV1 |
7.49795 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.49795 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.43893 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, NR3C1, PIK3CA, PTGS2, RORC, SMAD3, SRC, TRPV1 |
7.43406 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
7.42642 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, DRD2, DRD3, DRD4, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
7.33279 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, DRD2, DRD3, DRD4, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
7.33279 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GRIK5, HSPA1A, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
7.28107 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD17B2, NR3C1, PTGS2, RORC, SRC, TYR |
7.23026 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, INSR, MET, PIK3CA, PIM1, PTGS2, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR |
7.21803 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, PTGS2, SLC6A3, SRC |
7.1818 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FABP3, KDR, NR3C1, PTGS2, SLC6A2, SLC6A3, SRC, TRPV1 |
7.14909 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HSPA1A, PIK3CA, PIM1, PTGS1, PTGS2, TYR, XDH |
7.03618 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PTGS1, PTGS2 |
7.0104 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, NR3C1, PTGS2, SRC, TEK, TRPV1 |
6.98906 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
6.9644 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.96089 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
6.93792 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, GRM5, IGF1R, INSR, NR3C1, PTGS2, SMAD3, SRC, TEK, TRPV1 |
6.93792 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, SLC6A3, TYR |
6.89316 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, SLC1A1, TRPV1 |
6.85504 |
[BP] GO:0007193 |
None
|
CHRM2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
6.85504 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, ALOX12, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, PIM1, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
6.83395 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GRIK5, HSPA1A, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
6.81451 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GRIK5, HSPA1A, IGF1R, KDR, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
6.81173 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.61759 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NR3C1, NUAK1, PIK3CA, PTGS2, PTPN1, RORC, SMAD3, SRC, TRPV1 |
6.52497 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, ALOX12, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, GPR35, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TRPV1 |
6.52299 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.46165 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.21447 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, EGFR, FABP3, FLT3, GRM1, GRM5, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.21249 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, EGFR, FABP3, FLT3, GRM1, GRM5, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.21249 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
DRD2, EGFR, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.21249 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
6.15947 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.11697 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.10942 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
6.03395 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.93549 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.90162 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
5.88502 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TRPV1 |
5.84797 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FABP4, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.79652 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, SMAD3, SRC, TEK, TYR |
5.72479 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.71426 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.6853 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
5.67014 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, SLC1A1, TRPV1 |
5.57378 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
5.57378 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.57378 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.5073 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, SMAD3, TRPV1 |
5.48765 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TYR, XDH |
5.47277 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, PTGS2, SLC6A3, SRC, TEK, TRPV1, TYR |
5.47165 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.46568 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.46568 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.43158 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, ALOX12, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
5.39387 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
5.35836 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, ALOX12, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
5.35836 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.34818 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
5.33094 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B2 |
5.2911 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, KDR, SLC6A3, SRC |
5.26508 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B2 |
5.26399 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.24755 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.19127 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
5.10186 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
5.10176 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, PTGS2, SLC6A3, SRC, TEK, TRPV1, TYR |
5.09 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.09 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, DRD2, DRD4, EGFR, FLT3, GRM1, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH |
5.09 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, ALOX12, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
5.08574 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, DRD2, DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH |
5.05086 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.0155 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.0084 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, EGFR, HSPA1A, SLC6A3 |
4.94524 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
4.9401 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SRC, TRPV1 |
4.9401 |
[BP] GO:0043549 |
regulation of kinase activity
|
CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.92741 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.89496 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
4.8893 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.83424 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, NR3C1, PIK3CA, PTGS2, RORC, SRC, TRPV1 |
4.81094 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, RORC, SRC |
4.80978 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.78758 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.783 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.7655 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
4.75034 |
[BP] GO:0007188 |
None
|
CHRM2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.75004 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, PIM1, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TYR |
4.74248 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, PIM1, PTGS2, TEK |
4.73414 |
[BP] GO:0007268 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.73414 |
[BP] GO:0098916 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.73414 |
[BP] GO:0051338 |
regulation of transferase activity
|
AURKB, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.68268 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, ALOX12, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
4.68029 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
4.65999 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B2 |
4.65999 |
[BP] GO:0099536 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.65999 |
[BP] GO:0099537 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.65999 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
4.65999 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
4.65999 |
[BP] GO:0019725 |
cellular homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, SMAD3, TRPV1 |
4.63886 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD2, DRD3, EGFR, KDR, PIK3CB, PTGS2, SRC, TRPV1 |
4.62897 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.62897 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
4.62577 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GPR35, GRM3, IGF1R, MET, PIM1, PTGS2, PTPN1, SRC |
4.58724 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, SLC1A1, SLC6A2, SLC6A3, TRPV1 |
4.58703 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.58263 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.58263 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
4.57872 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
4.55493 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH |
4.55241 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1, RORC |
4.54294 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP4, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, XDH |
4.54278 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, PIK3CA, PIK3CB, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
4.54278 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, PTGS2, SMAD3, SRC, TEK |
4.53696 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
4.51795 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 |
4.51023 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
4.47415 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, PTGS2, SLC6A3 |
4.45649 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.45072 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4, PTGS2 |
4.42534 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5, PTGS2 |
4.42534 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, KDR, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.41092 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, SMAD3 |
4.39851 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, INSR, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TYR |
4.38233 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
4.34818 |
[BP] GO:0007187 |
None
|
CHRM2, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.33264 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
CDC25B, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
4.33264 |
[BP] GO:0060078 |
None
|
DRD4, GRIA2, GRIA4, GRIK5, GRM5, TRPV1 |
4.31804 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
4.31791 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
4.31791 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, PTGS2, PTPN1, SRC, XDH |
4.31724 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, PIK3CA, PIK3CB, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
4.24562 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, PIK3CB, PTPN1, SRC |
4.24466 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.22513 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.22513 |
[BP] GO:0007154 |
None
|
AXL, BCL2, CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC1A1, SLC6A2, TEK, TRPV1 |
4.18186 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, EGFR, GPR35, GRIK5, GRM5, HSPA1A, INSR, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TRPV1 |
4.18056 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.18056 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, EGFR, GRM1, HSPA1A, PTGS2, SMAD3, SRC, TEK, TRPV1, TYR |
4.13386 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CHRM2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 |
4.12705 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, XDH |
4.1034 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
4.1034 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, PIK3CA, PIK3CB, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
4.10235 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.09898 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TEK, TYR |
4.08836 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.05879 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.05879 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.01518 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.99892 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, NR3C1, PTGS2, SRC, TRPV1 |
3.99015 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC, TRPV1 |
3.97977 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.97977 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.97977 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH |
3.97927 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
3.96447 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP3, FABP4, GPR35, GRM3, GRM8, HSPA1A, IGF1R, KDR, MET, NR3C1, PIK3CA, PIM1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
3.94435 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.94316 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.86085 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX12, ALOX15, BCL2, CYP19A1, DRD2, DRD3, DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, XDH |
3.85444 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PTGS1, PTGS2 |
3.83963 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, NR3C1, PTGS2, SRC |
3.83187 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3, TRPV1 |
3.79264 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, NR3C1, PTGS2, SRC |
3.77341 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, ALOX12, AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, DRD3, EGFR, ESR1, GPR35, GRM1, HSPA1A, INSR, KDR, MET, PIK3CA, PIM1, PTGS2, SLC1A1, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
3.74936 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, EGFR, PIK3CB, PTGS2 |
3.73733 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.72472 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.72472 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, PIK3CA, PIK3CB, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.72472 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
3.692 |
[BP] GO:0042391 |
None
|
BCL2, DRD4, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC, TRPV1 |
3.69154 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.68634 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP3, FABP4, GPR35, GRM3, GRM8, HSPA1A, IGF1R, KDR, MET, NR3C1, PIK3CA, PIM1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
3.68245 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, HSPA1A, KDR, MET, PIM1, PTGS2, SLC1A1, SLC6A3, SMAD3, SRC, TEK, TRPV1 |
3.67643 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.67631 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, SLC6A3, TYR |
3.66756 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB |
3.66381 |
[BP] GO:0032147 |
activation of protein kinase activity
|
DRD2, DRD4, EGFR, GRM1, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
3.66026 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HSD11B1, HSD17B2 |
3.62125 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.61987 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.61987 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.59659 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B2 |
3.56364 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR |
3.55421 |
[BP] GO:0044057 |
None
|
ADORA3, CHRM2, DRD2, DRD3, EGFR, GPR35, GRM1, PTGS2, SLC1A1, SMAD3, TRPV1 |
3.55405 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
3.54876 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.53943 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
3.50349 |
[BP] GO:0044093 |
positive regulation of molecular function
|
AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, XDH |
3.4945 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, PTGS1, PTGS2 |
3.48293 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
BCL2, DRD2, DRD4, GPR35, PTGS2 |
3.44635 |
[BP] GO:0007610 |
None
|
BCL2, DRD2, DRD3, DRD4, EGFR, GRM1, GRM5, INSR, PTGS2, SLC6A3, TRPV1 |
3.40824 |
[BP] GO:0045927 |
positive regulation of growth
|
ALOX12, BCL2, CSNK2A1, DRD2, EGFR, INSR, PIM1, SLC6A3 |
3.40824 |
[BP] GO:0040008 |
regulation of growth
|
ALOX12, BCL2, CSNK2A1, DRD2, DRD3, EGFR, HSPA1A, INSR, PIK3CA, PIM1, SLC6A3, SMAD3 |
3.39741 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, PTGS1, PTGS2, SRC |
3.38911 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, PIK3CA, SLC6A3 |
3.38911 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, ALOX12, DRD2, MET, PIK3CA, TRPV1 |
3.38215 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.38122 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD2, DRD3, EGFR, ESR1, FABP4, KDR, MET, PTGS2, SLC6A3, SMAD3, TEK |
3.33603 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GRM5, IGF1R, INSR, PTGS2, SRC, TEK, TRPV1 |
3.33592 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.33592 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.33592 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.33592 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.33397 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
CA2, CA7, DRD2, DRD4, EGFR, PTGS2 |
3.33181 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
DRD4, EGFR, FLT3, GRM1, INSR, PIK3CB, PTPN1, SRC |
3.31835 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, ALOX15, BCL2, CYP1B1, DUSP3, KDR, NUAK1, PIK3CA, PIK3CB, SMAD3, SRC, TEK |
3.31137 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.30526 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.28642 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.261 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.261 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.261 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.24134 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, EGFR, ESR1, FLT3, GRM5, IGF1R, INSR, NR3C1, PTGS2, SMAD3, SRC, TRPV1 |
3.23425 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.22027 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
3.21859 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, EGFR, GRM5, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
3.16834 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.16172 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
3.15607 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.15333 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.13645 |
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1, TRPV1 |
3.13524 |
[BP] GO:0003008 |
None
|
AKR1B1, BCL2, CYP1B1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, INSR, PIK3CA, PTGS2, SLC6A3, SRC, TEK, TRPV1, TYR |
3.12772 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.11358 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, EGFR, INSR, PTGS2, SMAD3, SRC, TRPV1 |
3.10073 |
[BP] GO:1901570 |
None
|
ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 |
3.06531 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, HSD17B2, INSR, PTGS2, SRC |
3.04066 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, NR3C1, PTGS2 |
3.03205 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
3.02495 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.02495 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
3.02495 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
3.02495 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
3.02495 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
3.02374 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, DRD2, DRD3, DRD4, GPR35, PTGS2 |
3.01052 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.95884 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK |
2.95371 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, PIK3CB, PTPN1, SRC |
2.95136 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.94618 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, CA2, CHRM2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, INSR, PIK3CA, PIK3CB, SRC |
2.94336 |
[BP] GO:0009410 |
None
|
DRD2, DRD3, DRD4, EGFR, NR3C1, SLC6A3 |
2.93254 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.93229 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.93229 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, ALOX15, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, EGFR, HSPA1A, NUAK1, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC6A2, SMAD3, SRC, TEK, TRPV1 |
2.92026 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, PTGS2 |
2.90432 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, ALOX15, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
2.9017 |
[BP] GO:0007267 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
2.89585 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, ALOX15, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
2.89533 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.89452 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.89314 |
[BP] GO:0080134 |
regulation of response to stress
|
ALOX12, CYP19A1, DRD2, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.8757 |
[BP] GO:0051726 |
regulation of cell cycle
|
AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SMAD3, SRC |
2.85263 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, ALOX15, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
2.84607 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.83478 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.82531 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.77206 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.77206 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, PTGS2, PTPN1, SRC |
2.75667 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA3, ALOX15, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
2.71747 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
AURKB, BCL2, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
2.71657 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, PTGS2, SRC, TRPV1, TYR |
2.7101 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.70006 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.70006 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.70006 |
[BP] GO:0030258 |
lipid modification
|
ALOX12, CYP1A1, CYP3A4, EGFR, MET, PIK3CA, PIK3CB |
2.68945 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB |
2.67235 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
2.66923 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, PTGS1, PTGS2 |
2.66664 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.65036 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.65036 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.65036 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.65036 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP4, GRM3, GRM8, HSPA1A, IGF1R, KDR, MET, NR3C1, PIK3CA, PTGS2, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.64092 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.62553 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.62553 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.62553 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.62553 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.62553 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, PTGS2 |
2.59837 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.58613 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.58287 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, TYR, XDH |
2.58287 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, SRC |
2.57829 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
DRD4, EGFR, FLT3, GRM1, INSR, PIK3CB, PTPN1, SRC |
2.57091 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.56521 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.56521 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, PIK3CA, PIK3CB, RORC, SMAD3, SRC, TRPV1 |
2.56202 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, PTGS2, SMAD3, SRC, TEK |
2.55315 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.54724 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.54724 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, SRC |
2.54724 |
[BP] GO:0023052 |
None
|
CHRM2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
2.54559 |
[BP] GO:0050793 |
regulation of developmental process
|
ALOX12, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, INSR, KDR, NUAK1, PIK3CA, PIM1, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
2.54559 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.53875 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.53206 |
[BP] GO:0007626 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
2.52738 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.48703 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, DRD3, FABP3, FLT3, PTGS2, RORC, SRC, TEK |
2.48703 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, PTGS2, SMAD3, SRC, TEK |
2.484 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.47273 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.47273 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.45775 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.45775 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, DUSP3, FABP4, GRM3, GRM8, IGF1R, PTPN1, XDH |
2.45093 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, TEK |
2.45023 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, DUSP3, FABP4, GRM3, GRM8, IGF1R, PTPN1, XDH |
2.44695 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PTGS1, PTGS2 |
2.43368 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.41849 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX12, ALOX15, AURKB, AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, GRIK5, HSPA1A, IGF1R, INSR, KDR, MET, PIK3CB, PTPN1, SMAD3, SRC, TEK |
2.38634 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.38634 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD2, DRD3, SLC6A3, SMAD3, TEK |
2.38 |
[BP] GO:0070848 |
response to growth factor
|
EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
2.38 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.3776 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.3776 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.3772 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GRM3, GRM8, HSPA1A, IGF1R, MET, NR3C1, PIK3CA, PTGS2, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.37658 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CYP1A1, EGFR, PTGS2, TRPV1, TYR |
2.37658 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.37658 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.37658 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.37658 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37658 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.37391 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, SRC |
2.36713 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 |
2.33853 |
[BP] GO:0009416 |
response to light stimulus
|
AURKB, BCL2, DRD2, DRD3, EGFR, PTGS2, TYR |
2.33853 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, EGFR, KDR, SRC, TEK |
2.33342 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.32772 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.32772 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.32772 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PTGS2, SRC, TEK |
2.32619 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, PTGS2, SRC, TEK |
2.29504 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, PTGS2, SMAD3, SRC, TEK |
2.29205 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.28463 |
[BP] GO:0050877 |
None
|
CYP1B1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, INSR, PTGS2, SLC6A3, TRPV1, TYR |
2.28356 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B2 |
2.28356 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, EGFR, GRM5, IGF1R, INSR, PTGS2, SRC, TRPV1 |
2.27964 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.26067 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.23964 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.23964 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.23964 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.23964 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.23964 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.23964 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.23964 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
2.23659 |
[BP] GO:0098657 |
import into cell
|
ACHE, ALOX15, AXL, DRD2, DRD3, SLC1A1, SLC6A2, SLC6A3, TRPV1 |
2.23474 |
[BP] GO:0046683 |
response to organophosphorus
|
PTGS2, SLC6A3, TEK, TRPV1, TYR |
2.23292 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.23292 |
[BP] GO:0060079 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.22409 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, PTGS2, SRC, TRPV1, TYR |
2.21998 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.20511 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.20511 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.20511 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB |
2.19896 |
[BP] GO:0009411 |
response to UV
|
AURKB, BCL2, EGFR, PTGS2, TYR |
2.19836 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.16546 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.16504 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.16282 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, PTGS2, PTPN1, SMAD3, SRC, TEK |
2.16163 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.16106 |
[BP] GO:0007612 |
None
|
DRD2, DRD3, GRM5, INSR, PTGS2 |
2.16106 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
2.15259 |
[BP] GO:0048638 |
regulation of developmental growth
|
BCL2, DRD2, DRD3, INSR, PIK3CA, PIM1, SLC6A3 |
2.15259 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, AXL, DRD2, PIK3CB, PTPN1, SRC |
2.1318 |
[BP] GO:0071383 |
None
|
EGFR, FLT3, NR3C1, SRC |
2.1296 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.12899 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.12899 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.12899 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, GPR35 |
2.11228 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TRPV1, XDH |
2.10228 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.09322 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.09221 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.09221 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.09221 |
[BP] GO:0030799 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.09166 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, EGFR, GRM5, IGF1R, INSR, PTGS2, SRC, TRPV1 |
2.09166 |
[BP] GO:0000187 |
activation of MAPK activity
|
DRD4, GRM1, INSR, PIK3CB, PTPN1 |
2.07845 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, PTGS2, SRC |
2.07827 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
CDC25B, CYP1A1, DRD3, DUSP3, INSR |
2.07187 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.07187 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.07187 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.07187 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.07187 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.07187 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.07187 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.07187 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.07187 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.07187 |
[BP] GO:0022898 |
None
|
BCL2, DRD2, DRD3, DRD4, GPR35, GRM5 |
2.07097 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.07097 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.07097 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.07097 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.07097 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.07097 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ALOX12, AXL, BCL2, CA2, CYP1B1, DRD2, INSR, KDR, PIM1, PTGS2, SLC6A3, SMAD3, SRC, TEK |
2.07051 |
[BP] GO:0006954 |
inflammatory response
|
ADORA3, ALOX15, AXL, PIK3CA, PIK3CB, PTGS1, PTGS2, TRPV1 |
2.06554 |
[BP] GO:0014074 |
response to purine-containing compound
|
PTGS2, SLC6A3, TEK, TRPV1, TYR |
2.05816 |
[BP] GO:0040018 |
None
|
BCL2, DRD2, SLC6A3 |
2.03426 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.03426 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX12, ALOX15, CYP1A1, PTGS1, PTGS2 |
2.03395 |
[BP] GO:0008217 |
None
|
DRD2, DRD3, PTGS1, PTGS2, SMAD3 |
2.02118 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, INSR |
2.01921 |
[BP] GO:1901655 |
None
|
AKR1B1, EGFR, NR3C1, SRC |
2.01921 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.0109 |
[BP] GO:0007611 |
None
|
DRD2, DRD3, EGFR, GRM5, INSR, PTGS2 |
2.0109 |
[BP] GO:0009888 |
tissue development
|
ALOX15, ALPL, CYP1B1, INSR, KDR, PIK3CA, PTGS2, RORC, SMAD3 |
2.00672 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.0027 |
[BP] GO:0008286 |
None
|
IGF1R, INSR, PIK3CA, PTPN1 |
2.0027 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.00204 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, ALOX12, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1 |
7.82741 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, ALOX15, AXL, CA2, CA4, CA9, CHRM2, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTGS2, SLC1A1, SLC6A2, SLC6A3, SRC, TEK, TRPV1 |
7.43893 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX12, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR |
7.21803 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TEK, TRPV1, TYR |
7.21803 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, AXL, CA4, CHRM2, DRD2, DRD3, DRD4, F10, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK, TRPV1 |
6.96089 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, CHRM2, DRD2, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, PTGS2, SLC1A1, SRC, TEK, TRPV1 |
6.96089 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, AXL, CHRM2, DRD2, DRD3, DRD4, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK, TRPV1 |
5.94606 |
[CC] GO:0044456 |
None
|
ACHE, CHRM2, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC, TRPV1 |
4.52793 |
[CC] GO:0097060 |
None
|
CHRM2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, TRPV1 |
3.94274 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.53691 |
[CC] GO:0043005 |
None
|
CA2, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SLC6A2, SLC6A3, SRC |
3.29234 |
[CC] GO:0042995 |
cell projection
|
AKR1B1, CA2, CHRM2, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
3.1345 |
[CC] GO:0097458 |
None
|
CA2, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, PTGS1, PTGS2, SLC6A2, SLC6A3, SRC, TRPV1 |
3.08041 |
[CC] GO:0045121 |
membrane raft
|
EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
3.03205 |
[CC] GO:0098857 |
membrane microdomain
|
EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
3.02374 |
[CC] GO:0120025 |
None
|
AKR1B1, CA2, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
2.8757 |
[CC] GO:0043235 |
receptor complex
|
EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
2.7853 |
[CC] GO:0031224 |
None
|
ACHE, ADORA3, ALPL, AXL, CA12, CA14, CA4, CA9, CHRM2, CYP3A4, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FLT3, FUT7, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK, TRPV1, TYR |
2.6077 |
[CC] GO:0098589 |
membrane region
|
EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
2.55158 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, F10, FLT3, GRIA2, HSD11B1, HSD17B2, PTGS1, PTGS2, PTPN1 |
2.43426 |
[CC] GO:0014069 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.32627 |
[CC] GO:0099572 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.32627 |
[CC] GO:0044463 |
None
|
AKR1B1, CA4, CA9, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM3, INSR, PTGS1, SRC, TRPV1 |
2.2188 |
[CC] GO:0120038 |
None
|
AKR1B1, CA4, CA9, CHRM2, DRD2, GRIA2, GRIA4, GRIK5, GRM3, INSR, PTGS1, SRC, TRPV1 |
2.2188 |
[CC] GO:0045211 |
None
|
CHRM2, GRIA2, GRIA4, GRIK5, GRM3, TRPV1 |
2.20511 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, GRIA2, HSD11B1, HSD17B2, PTGS1, PTGS2 |
2.19369 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.07187 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, HSD11B1, HSD17B2, HSPA1A, INSR, KDR, NQO2, NR3C1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TRPV1, TYR, XDH |
2.07149 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
11.9427 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
9.73735 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, NQO2, NR3C1, PIM1, PTPN1, RORC, SMAD3, TYR, XDH |
9.20866 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SLC6A3, SRC, TEK, TRPV1 |
8.95658 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.20851 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, RORC, TEK, TRPV1 |
8.02493 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.67128 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.33681 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, RORC, TEK, TRPV1 |
7.1599 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, RORC, SMAD3, TEK, TRPV1 |
7.04881 |
[MF] GO:0030594 |
None
|
CHRM2, DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
6.96089 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NR3C1, RORC, TEK, TRPV1 |
6.96089 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
6.88734 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, FLT3, FUT7, HSD11B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TEK, TYR, XDH |
6.81451 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
6.79037 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
6.79037 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.76581 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.49031 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, ESR1, F10, NQO2, NR3C1, NUAK1, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SMAD3, TRPV1, TYR, XDH |
6.22497 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.71426 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.37904 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.33058 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
5.30518 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.13912 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
5.09 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
5.0069 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
4.7655 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, TYR |
4.7655 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.73414 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.65033 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, F10, NQO2, NR3C1, NUAK1, PIM1, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SMAD3, TRPV1, TYR, XDH |
4.45475 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
4.31902 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.24696 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.13386 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, IGF1R, INSR, NQO2, NR3C1 |
4.10182 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.06955 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.85444 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5, PTGS2 |
3.65449 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.61987 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5, PTGS2 |
3.59659 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
3.48213 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.4687 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.4687 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
3.23446 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, NQO2, NR3C1, PTPN1, RORC, SMAD3 |
3.20289 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.11358 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1, PTGS2, SRC, XDH |
3.08001 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.02495 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
3.02495 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, BCL2, CSNK2A1, DRD2, DRD4, EGFR, ESR1, FLT3, GRIK5, IGF1R, KDR, MET, NQO2, PTGS2, SMAD3, TRPV1, TYR, XDH |
2.85903 |
[MF] GO:0051213 |
dioxygenase activity
|
ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 |
2.85903 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1 |
2.84025 |
[MF] GO:0005231 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.71988 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1 |
2.71988 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1 |
2.69198 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PTPN1, SLC6A3, SMAD3 |
2.68945 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.62553 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.62553 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.62553 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.62553 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.62553 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.62553 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.58287 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.58287 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AURKB, AXL, CSNK2A1, EGFR, F10, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SLC1A1, SRC, TEK, TRPV1, XDH |
2.58287 |
[MF] GO:0036094 |
small molecule binding
|
AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SLC1A1, SRC, TEK, TRPV1, XDH |
2.56618 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.54724 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, MET, PTPN1, SLC6A3 |
2.38634 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.3776 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.3776 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.3776 |
[MF] GO:0099094 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.30437 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.28356 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.23292 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.22409 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.20511 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.20511 |
[MF] GO:0051721 |
None
|
BCL2, PTPN1, SLC6A3 |
2.16282 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD11B1, HSD17B2, XDH |
2.16106 |
[MF] GO:0019900 |
None
|
AURKB, CDC25B, DUSP3, EGFR, ESR1, GRM5, NR3C1, PTPN1, SMAD3, SRC |
2.14524 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.1296 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.12899 |
[MF] GO:0005230 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.11228 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1, XDH |
2.09419 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TRPV1, XDH |
2.09322 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, F10, FABP3, FABP4, NR3C1, RORC, TRPV1 |
2.07415 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.07187 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.07187 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.07097 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.03426 |